Quick answer
What is pancreatic cancer?
Pancreatic cancer is an aggressive cancer of the pancreas — often diagnosed late because early symptoms are vague. Red flags include jaundice (yellow skin and eyes), unexplained weight loss, new-onset diabetes in over 50s, pale stools and dark urine, upper tummy pain going through to back, and indigestion not responding to treatment. Only about 10% are suitable for curative surgery. See a GP urgently for jaundice or significant unexplained weight loss — 2-week wait referral. Smoking and chronic pancreatitis increase risk.
Pancreatic cancer — why early diagnosis matters
Pancreatic cancer is one of the deadliest common cancers — ~10,500 UK cases/year — 5-year survival under 10% overall because most present with advanced disease.
Pancreatic ductal adenocarcinoma (PDAC) — 90% of cases
Symptoms — when to investigate
High suspicion:
- Painless jaundice — pale stools, dark urine, itching
- Unexplained weight loss
- Upper abdominal pain → back — worse supine
- New diabetes + weight loss over 50
- Thrombosis — migratory superficial thrombophlebitis (Trousseau sign)
Non-specific (still investigate if persistent):
- Indigestion not responding to PPI
- Appetite loss
- Fatigue
See jaundice symptom guide — not always alcohol or hepatitis
Diagnosis pathway
- Urgent CT pancreas — dual phase
- Tumour markers — CA19-9 — Lewis antigen negative patients may not express
- EUS + FNA biopsy — tissue confirmation
- Staging — CT chest/abdomen/pelvis — laparoscopy if borderline resectable
Resectability categories:
- Resectable
- Borderline — neoadjuvant chemo first
- Locally advanced — unresectable
- Metastatic
Treatment
Surgery (curative intent):
- Whipple (pancreaticoduodenectomy) — head tumours
- Distal pancreatectomy — body/tail
- High-volume centre — outcomes differ
Chemotherapy:
- Adjuvant post-surgery — FOLFIRINOX fit patients
- Metastatic — FOLFIRINOX or gem/nab-paclitaxel
- Palliative — symptom control, modest survival gain
Supportive:
- Biliary stent — ERCP — relieves jaundice
- Pancreatic enzymes — steatorrhoea
- Pain team — coeliac plexus block
Risk reduction
- Stop smoking
- Healthy weight
- Limit alcohol — chronic pancreatitis risk
Screening only in high-risk families — BRCA, Lynch, FAMMM — specialist programmes
After diagnosis
Pancreatic Cancer UK support line
Clinical nurse specialist
Advance care planning — realistic hope with aggressive treatment where appropriate
Jaundice + weight loss — GP same week — not wait for painless to mean harmless.
Common questions
- What are the early symptoms of pancreatic cancer?
- Often none or non-specific — indigestion, appetite loss, fatigue. As tumour grows — weight loss, upper abdominal pain radiating to back, jaundice if bile duct blocked, pale stools, dark urine, new diabetes, deep vein thrombosis without clear cause. Symptoms overlap many benign conditions — persistent or progressive features need scanning.
- How is pancreatic cancer diagnosed?
- CT pancreas protocol first — identifies mass and staging. MRI or EUS (endoscopic ultrasound) for detail and biopsy. ERCP with stent if jaundiced. CA19-9 tumour marker — not diagnostic alone. Laparoscopy in selected cases before major surgery. Staging determines resectability — only 10–15% resectable at diagnosis.
- Can pancreatic cancer be cured?
- Surgical resection (Whipple procedure or distal pancreatectomy) offers only curative option — for localised tumours without major vessel involvement or distant spread. Adjuvant chemotherapy (FOLFIRINOX or gemcitabine/capecitabine) after surgery improves survival. Most patients present too late for surgery — palliative chemo extends life and controls symptoms.
- What causes pancreatic cancer?
- Smoking — strongest modifiable risk — doubles risk. Chronic pancreatitis, obesity, diabetes, family history (BRCA2, Lynch syndrome, Peutz-Jeghers), heavy alcohol. Most cases sporadic without clear cause. Age — peak 65–79.
- What is the Whipple procedure?
- Pancreaticoduodenectomy — removes head of pancreas, duodenum, part of bile duct and stomach, gallbladder — reconnects bowel. Major operation — 2-week hospital stay, lifelong pancreatic enzyme supplements and often diabetes afterward. Mortality under 5% in high-volume centres.